Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multi-Center Continued Access Protocol for the Use of the LifePort® Liver Transporter (LLT) System With Vasosol® in Orthotopic Liver Transplants (PILOT™_CA: Perfusion to Improve Liver Outcomes in Transplantation_ Continued Access Arm)

NCT05574361 is registered in ClinicalTrials.gov with Organ Recovery Systems, Inc. as lead sponsor.

NCT NCT05574361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05574361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multi-Center Continued Access Protocol for the Use of the LifePort® Liver Transporter (LLT) System With Vasosol® in Orthotopic Liver Transplants (PILOT™_CA: Perfusion to Improve Liver Outcomes in Transplantation_ Continued Access Arm)
Lead sponsor
Organ Recovery Systems, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 19, 2022
Completion date
October 23, 2026
Enrollment
385 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplantation